Pneumology - Case Reports Open access

Fungal pneumonia concealing bacterial pneumonia: a diagnostic dilemma

Authors

Published
4 September 2023
Section
Pneumology - Case Reports
DOI
10.4081/monaldi.2023.2683

Abstract

We describe the case of a 61-year-old diabetic man affected by Achromobacter denitrificans. He was immunocompetent and did not have any past history of chronic lung disease. The patient was treated with sensitive antibiotic meropenem 1 g, three times daily. To our knowledge, only one case of A. denitrificans pneumonia has been reported from the Indian subcontinent in an individual with underlying lung disease and none in a healthy person.

Keywords

References

  1. Swenson CE, Sadikot RT. Achromobacter respiratory infections. Ann Am Thorac Soc 2015;12:252-8.
  2. Spear JB, Fuhrer J, Kirby BD. Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature. J Clin Microbiol 1988;26:598-9.
  3. Stepman G, Dabb K, Khan IA, et al. Bilateral pneumonia in a patient with chronic bronchiectasis caused by Achromobacter xylosoxidans subspecies denitrificans. Cureus 2020;12:e7381.
  4. Aundhakar S, Mane M, Bharadiya A, Pawar S. Watch out! Pneumonia secondary to Achromobacter denitrificans. Ann Med Health Sci Res 2014;4:S22-4.
  5. Habib S, Fuca N, Azam M, et al. Achromobacter xylosoxidans/denitrificans bacteremia and subsequent fatal Escherichia coli/Streptococcus anginosus pleural empyema. Respir Med Case Rep 2018;25:311-3.
  6. Awadh H, Mansour M, Aqtash O, Shweihat Y. Pneumonia due to a rare pathogen: Achromobacter xylosoxidans, subspecies denitrificans. Case Rep Infect Dis 2017;2017:3969682.
  7. Duggan JM, Goldstein SJ, Chenoweth CE, et al. Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis 1996;23:569-76.

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2023 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.